MargheRITA (Remote Intelligence for Therapeutic Adherence)
Conditions:   Multiple Myeloma;   Solitary Plasmacytoma;   Amyloidosis;   Chronic Myeloid Leukemia;   Chronic Lymphocytic Leukemia;   T Cell Non-Hodgkin Lymphoma;   Lymphocytic Lymphoma;   Hodgkin Lymphoma;   B-cell Non Hodgkin Lymphoma;   Acute Myeloid Leukemia;   Myelodysplasia;   Chronic Myeloproliferative Disorder;   Treatment Adherence;   Treatment Adherence and Compliance Intervention:   Device: RITA (App) Sponsor:   Advice Pharma Group srl Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2022 Category: Research Source Type: clinical trials

Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma
Condition:   Solitary Plasmacytoma Interventions:   Radiation: radiotherapy;   Drug: Bortezomib Injection;   Drug: Lenalidomide;   Drug: Dexamethasone Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2022 Category: Research Source Type: clinical trials